Peptide Encyclopaedia
Botulinum toxin
Also known as Botox, OnabotulinumtoxinA.
Approved-medicine listing only. This is not available from the Cellular Sequence shop. Licensed products require a prescriber and an ARTG-registered presentation.
At-a-glance profile
- Classification
- Bacterial neurotoxin protein (not a cosmetic hexapeptide)
- Approval status
- Approved medicine
- Research status
- Labelled indications are defined in product information.
- Molecular formula
- Insufficient reliable evidence identified.
- Molecular weight
- Insufficient reliable evidence identified.
- Sequence
- High-molecular-weight toxin; licensed units are not interchangeable with ‘100 IU research vials’.
- Primary biological target
- Insufficient reliable evidence identified.
- Half-life
- Insufficient reliable evidence identified.
- Routes investigated
- Insufficient reliable evidence identified.
- Human evidence level
- A — Approved clinical use / strong human evidence
What is it?
Licensed neuromodulator medicines exist for wrinkles and medical indications. Anonymous toxin vials are a public-health hazard.
Mechanism of action
Cleaves SNARE proteins and blocks acetylcholine release at the neuromuscular junction.
Local paralysis; distant spread can be life-threatening.
What is it being studied for?
- Licensed aesthetic and medical indications
Investigational findings are not proven clinical benefits unless an authority has labelled that indication.
Evidence level
Overall human evidence grade: A · Approved clinical use / strong human evidence
Human research
Extensive for licensed brands; zero for unnamed vials.
Preclinical research
Animal, cell and in-vitro findings are listed separately from human effects.
Clostridial toxin mechanism is known — that is why counterfeit toxin is so dangerous.
Doses reported in published research
This section does not provide personalised medical dosing. Values are those reported in papers or protocols. Animal mg/kg doses are not converted to human doses.
Doses reported in human studies
Insufficient reliable evidence identified.
Preclinical / animal study dosing
Insufficient reliable evidence identified.
Pharmacokinetics
Reliable human pharmacokinetic data were not identified for this encyclopaedia entry, or are limited to product information for approved presentations.
Safety
Dysphagia, respiratory compromise, antibody formation.
Unknowns. Absence of a published harm signal is not evidence of safety.
Contraindications. Never inject non-licensed toxin.
Regulatory status
Approved as specific branded biologics; unlicensed toxin is illegal to supply as a medicine.
Cellular Sequence does not sell this as a vial, tablet, oil, or injectable. Educational encyclopaedia listing only.
Citations
[1] Encyclopaedia note
Encyclopaedia note
For educational and research reference only. This page summarises published scientific literature and does not constitute medical advice, prescribing information or a recommendation to use an investigational compound. Research doses shown describe doses reported in published studies and are not personalised dosing instructions.
Last reviewed 2026-09-13. Research areas: Skin & Hair · Compare peptides